minoxidil has been researched along with EHS Tumor in 1 studies
Minoxidil: A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)
minoxidil : A pyrimidine N-oxide that is pyrimidine-2,4-diamine 3-oxide substituted by a piperidin-1-yl group at position 6.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eisinger-Mathason, TS | 1 |
| Zhang, M | 1 |
| Qiu, Q | 1 |
| Skuli, N | 1 |
| Nakazawa, MS | 1 |
| Karakasheva, T | 1 |
| Mucaj, V | 1 |
| Shay, JE | 1 |
| Stangenberg, L | 1 |
| Sadri, N | 1 |
| Puré, E | 1 |
| Yoon, SS | 1 |
| Kirsch, DG | 1 |
| Simon, MC | 1 |
1 other study available for minoxidil and EHS Tumor
| Article | Year |
|---|---|
Hypoxia-dependent modification of collagen networks promotes sarcoma metastasis.
Topics: Animals; Cell Hypoxia; Cell Movement; Collagen; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; M | 2013 |